{
    "root": "2ad7b10a-e9c2-4a64-bea5-f939b62e4f03",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "fluticasone propionate and salmeterol",
    "value": "20250516",
    "ingredients": [
        {
            "name": "SALMETEROL XINAFOATE",
            "code": "6EW8Q962A5"
        },
        {
            "name": "FLUTICASONE PROPIONATE",
            "code": "O2GMZ0LF5W"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        }
    ],
    "indications": "Fluticasone propionate and salmeterol inhalation powder is a combination product containing a corticosteroid and a long-acting beta 2 -adrenergic agonist (LABA) indicated for: • Twice-daily treatment of asthma in patients aged 4 years and older. ( 1.1 ) • Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). ( 1.2 ) Important Limitation of Use: Not indicated for relief of acute bronchospasm. ( 1.1 , 1.2 )",
    "contraindications": "Fluticasone propionate and salmeterol inhalation powder should be administered as 1 inhalation twice daily by the orally inhaled route only. After inhalation, the patient should rinse his/her mouth with water without swallowing to help reduce the risk of oropharyngeal candidiasis.\n                  More frequent administration or a greater number of inhalations (more than 1 inhalation twice daily) of the prescribed strength of fluticasone propionate and salmeterol inhalation powder is not recommended as some patients are more likely to experience adverse effects with higher doses of salmeterol. Patients using fluticasone propionate and salmeterol inhalation powder should not use additional LABA for any reason [see Warnings and Precautions (\n                     Error! Hyperlink reference not valid.\n                     , 5.12)].",
    "warningsAndPrecautions": "Fluticasone Propionate and Salmeterol Inhalation Powder USP\n                  \n                  250 mcg/50 mcg is supplied as a disposable gray plastic inhaler containing a foil blister strip with 60 blisters. The inhaler is packaged in a plastic-coated, moisture-protective foil pouch (NDC 68788-8453-6).\n                  Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Store in a dry place away from direct heat or sunlight. Keep out of reach of children. \n                  Fluticasone propionate and salmeterol inhalation powder should be stored inside the unopened moisture-protective foil pouch and only removed from the pouch immediately before initial use. Discard fluticasone propionate and salmeterol inhalation powder 1 month after opening the foil pouch or when the counter reads “0” (after all blisters have been used), whichever comes first. The inhaler is not reusable. Do not attempt to take the inhaler apart.",
    "adverseReactions": "The use of fluticasone propionate and salmeterol inhalation powder is contraindicated in the following conditions:\n                  \n                     \n                        •Primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required [see Warnings and Precautions (5.2)].\n                     \n                        •Severe hypersensitivity to milk proteins or demonstrated hypersensitivity to fluticasone propionate, salmeterol, or any of the excipients [see Warnings and Precautions (5.11), Adverse Reactions (6.3), Description (11)]."
}